CollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs, and on developing and commercializing tissue repair products for orthobiologics, and advanced wound care markets. The Company's rhCollagen BioInk product line is used for 3D bioprinting of tissues and organs, and a Vergenix line of rhCollagen products includes a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote an optimal healing of acute and chronic wounds.
|HQ||Ness Ziona, IL||Map|
|Employees (est.) (Mar 2018)||39|
|Share Price (Dec 2019)||$5||(-5%)|
Market capitalization (10-Dec-2019)
Closing stock price (10-Dec-2019)
When was CollPlant founded?
CollPlant was founded in 1981.
Who are CollPlant key executives?
CollPlant's key executives are Yehiel Tal, Oded Shoseyov and Eran Rotem.
How many employees does CollPlant have?
CollPlant has 39 employees.
Who are CollPlant competitors?
Competitors of CollPlant include Cytori Therapeutics, Pharmanutra and Delcath Systems.
Where is CollPlant headquarters?
CollPlant headquarters is located at Pinhas Sapir St 3, Ness Ziona.
Where are CollPlant offices?
CollPlant has offices in Ness Ziona and New York.
How many offices does CollPlant have?
CollPlant has 2 offices.
Receive alerts for 300+ data fields across thousands of companies